Dasmahapatra, Girija <br/><br/>
Obatoclax interacts synergistically with the irreversible proteasome inhibitor carfilzomib in GC- and ABC-DLBCL cells in vitro and in vivo.  [electronic resource] 

 -  Molecular cancer therapeutics  May 2012 
 - 1122-32 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Retracted Publication 
<br/><br/><label>ISSN: </label>1538-8514 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-12-0021  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Apoptosis--drug effects<br/>Apoptosis Regulatory Proteins--metabolism<br/>Bcl-2-Like Protein 11<br/>Cell Line, Tumor<br/>Drug Synergism<br/>Germinal Center--drug effects<br/>Histones--metabolism<br/>Humans<br/>Indoles<br/>Lymphoma, Large B-Cell, Diffuse--drug therapy<br/>MAP Kinase Kinase 4--metabolism<br/>Membrane Proteins--metabolism<br/>Mice<br/>Mice, Nude<br/>Myeloid Cell Leukemia Sequence 1 Protein<br/>Oligopeptides--administration & dosage<br/>Proteasome Endopeptidase Complex--metabolism<br/>Proteasome Inhibitors<br/>Protein Binding<br/>Proto-Oncogene Proteins--metabolism<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Proto-Oncogene Proteins c-bcl-2--metabolism<br/>Pyrroles--administration & dosage<br/>Xenograft Model Antitumor Assays<br/>bcl-2 Homologous Antagonist-Killer Protein--metabolism<br/>bcl-2-Associated X Protein--metabolism